Exposure of adolescent mice to 3,4-methylenedioxypyrovalerone increases the psychostimulant, rewarding and reinforcing effects of cocaine in adulthood

Data de publicació

2020-07-03T09:36:10Z

2020-07-03T09:36:10Z

2017-04-06

2020-07-03T09:36:10Z

Resum

BACKGROUND AND PURPOSE 3,4-Methylenedioxypyrovalerone (MDPV) is a synthetic cathinone with powerful psychostimulant effects. It selectively inhibits the dopamine transporter (DAT) and is 10-50-fold more potent as a DAT blocker than cocaine, suggesting a high abuse liability. The main objective of the present study was to assess the consequences of an early (adolescence) MDPV exposure on the psychostimulant, rewarding and reinforcing effects induced by cocaine in adult mice. EXPERIMENTAL APPROACH Twenty-one days after MDPV pretreatment (1.5 mg/kg, s.c., twice daily for 7 days), adult mice were tested with cocaine, using locomotor activity, conditioned place preference and self-administration (SA) paradigms. In parallel, dopamine D2 receptor density and the expression of c-Fos and ΔFosB in the striatum were determined. KEY RESULTS MDPV treatment enhanced the psychostimulant and conditioning effects of cocaine. Acquisition of cocaine SA was unchanged in mice pretreated with MDPV, whereas the breaking point achieved under a progressive ratio programme and reinstatement after extinction were higher in this group of mice. MDPV decreased D2 receptor density but increased ΔFosB expression three-fold. As expected, acute cocaine increased c-Fos expression, but MDPV pretreatment negatively influenced its expression. ΔFosB accumulation declined during MDPV withdrawal, although it remained elevated in adult mice when tested for cocaine effects. CONCLUSION AND IMPLICATIONS MDPV exposure during adolescence induced long-lasting adaptive changes related to enhanced responsiveness to cocaine in the adult mice that seems to lead to a higher vulnerability to cocaine abuse. This particular behaviour correlated with increased expression of ΔFosB.

Tipus de document

Article


Versió acceptada

Llengua

Anglès

Publicat per

Blackwell

Documents relacionats

Versió postprint del document publicat a: https://doi.org/10.1111/bph.13771

British Journal of Pharmacology, 2017, vol. 174, num. 10, p. 1161-1173

https://doi.org/10.1111/bph.13771

info:eu-repo/grantAgreement/EC/H2020/634143/EU//MedBioinformatics

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

(c) The British Pharmacological Society, 2017

Aquest element apareix en la col·lecció o col·leccions següent(s)